<DOC>
	<DOC>NCT02607683</DOC>
	<brief_summary>This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).</brief_summary>
	<brief_title>Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)</brief_title>
	<detailed_description />
	<criteria>Moderate to severe, bilateral lower eyelid steatoblepharon Must understand and provide informed consent Healthy facial skin Pregnant or lactating women Clinically significant eye disease Best corrected visual acuity worse than 20/40 in either eye History of eye surgery in past 6 months History of lower eyelid surgery</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>